Hepatitis B virus (HBV) continues to be a major health issue in the United States despite prevention strategies.
May 3, 2011
0
0
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...
Apr 18, 2019
0
62
A 300-mg dose of bepirovirsen per week for 24 weeks results in sustained hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA loss in 9–10% of patients with chronic HBV infection, according to a study published ...
Nov 14, 2022
0
27
(HealthDay)—Metabolic syndrome (MetS) is prevalent among patients with chronic hepatitis B (HBV) infection, according to a study published online March 29 in Diabetes Care.
Apr 17, 2018
0
5
Researchers at Princeton University have identified a set of human proteins that the hepatitis B virus (HBV) uses to establish itself permanently inside liver cells. The study, published in the journal Nature Microbiology, ...
Mar 9, 2020
0
83
(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.
Aug 12, 2015
0
8
Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication. Findings published online in Hepatology, a journal of the American Association for the ...
Jun 6, 2013
0
0
(Medical Xpress)—Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing ...
Jan 9, 2013
0
0
It's been called the silent epidemic. Four million people worldwide are infected with chronic Hepatitis B (HBV) and in the United States over two million people have been diagnosed with the disease. The viral infection is ...
Oct 2, 2015
0
6
A new study presented today demonstrates a potential link between treatment of long-term oral nucleos(t)ide analogues and an increased risk of colorectal (p=0.029) and cervical (p=0.049) cancer in patients with chronic Hepatitis ...
Apr 15, 2016
0
0
